Cynosure Appoints Marina Hatsopoulos to Board of Directors
November 18 2008 - 8:30AM
PR Newswire (US)
Founding CEO of Z Corporation Brings Strong Experience as
Technology Entrepreneur, Business Leader WESTFORD, Mass., Nov. 18
/PRNewswire-FirstCall/ -- Cynosure, Inc. (NASDAQ:CYNO), a leading
developer and manufacturer of a broad array of light-based
aesthetic treatment systems, today announced the appointment of
Marina Hatsopoulos, 43, to the Company's seven-member Board of
Directors. Hatsopoulos replaces Paul Kelleher, 65, who has resigned
to pursue other interests. Hatsopoulos will serve on the Board's
Audit and Compensation Committees. Board member George Vojta will
succeed Paul Kelleher as Chairman of the Audit Committee. "We are
delighted to welcome to our board a leader with the breadth of
experience of Marina Hatsopoulos," said President and Chief
Executive Officer Michael Davin. "Her role in founding and guiding
a profitable growth company, and her corporate finance expertise,
will be important assets to Cynosure. She has a strong corporate
governance background as well as a track record of business
success, having led a technology company from startup to industry
leadership. We look forward to her valuable counsel and insights."
"We also would like to thank Paul Kelleher for his significant
contributions to Cynosure over the past three years," Davin said.
"As a director since 2005, he was part of the team that guided the
Company since its initial public offering. We wish Paul well in his
future endeavors." Hatsopoulos is currently a director of the GSI
Group (NASDAQ:GSIG), which supplies precision motion control
products, lasers and laser-based advanced manufacturing systems in
the global medical, semiconductor, electronics and industrial
markets. She also is a Director of Tea Forte, which sells
award-winning premium tea-related products into the gift and hotel
market. Hatsopoulos serves on the Advisory Board of the annual
Nantucket Conference, which brings together entrepreneurs,
investors, technologists and executives. Hatsopoulos was the
founding CEO of Z Corporation, a market leader in 3D printing, from
1994 through its sale in 2005. Prior to founding Z Corporation, she
worked in corporate finance for the Energy Industry at The Chase
Manhattan Bank in New York, negotiating $2.5 billion in financing
deals. Her experience also includes operational roles at various
Thermo Electron Corporation subsidiaries, where she headed up
special projects in mergers and acquisitions, marketing and project
management. Recently Hatsopoulos became a founding member of the
newly formed Advisory Board for the Massachusetts Institute of
Technology's Deshpande Center for Technological Innovation. The
Deshpande Center serves as a catalyst for innovation and
entrepreneurship by funding early-stage research to help new
technologies emerge. Hatsopoulos graduated with a B.A. in Pure
Mathematics and a B.A. in Music from Brown University. She received
her M.S. in Mechanical Engineering from MIT. About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems
that are used by physicians and other practitioners to perform
non-invasive and minimally invasive procedures to remove hair,
treat vascular lesions, rejuvenate skin through the treatment of
shallow vascular and pigmented lesions, liquefy and remove unwanted
fat through laser lipolysis and temporarily reduce the appearance
of cellulite. Cynosure's products include a broad range of laser
and other light-based energy sources, including Alexandrite, pulsed
dye, Nd:YAG and diode lasers, as well as intense pulsed light.
Cynosure was founded in 1991. For corporate or product information,
contact Cynosure at 800-886-2966, or visit
http://www.cynosure.com/. DATASOURCE: Cynosure, Inc. CONTACT: Scott
Solomon, Vice President of Sharon Merrill Associates, Inc.,
+1-617-542-5300, Web site: http://www.cynosurelaser.com/
http://www.cynosure.com/
Copyright
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jul 2023 to Jul 2024